Emerging concepts in drug discovery for cancer therapy

doi:10.1002/1878-0261.13325

Editorial

. 2022 Nov;16(21):3757-3760.

doi: 10.1002/1878-0261.13325.

Emerging concepts in drug discovery for cancer therapy

Matilde Murga¹, Oscar Fernandez-Capetillo^{1

2}

Affiliations

¹ Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
² Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.

PMID: 36321722
PMCID: PMC9627784
DOI: 10.1002/1878-0261.13325

Editorial

Emerging concepts in drug discovery for cancer therapy

Matilde Murga et al. Mol Oncol. 2022 Nov.

. 2022 Nov;16(21):3757-3760.

doi: 10.1002/1878-0261.13325.

Authors

Matilde Murga¹, Oscar Fernandez-Capetillo^{1

2}

Affiliations

¹ Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
² Science for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.

PMID: 36321722
PMCID: PMC9627784
DOI: 10.1002/1878-0261.13325

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

1. UK CR . Cancer survival statistics for all cancers combined. 2022. [cited 2022 September 01]. Available from: https://wwwcancerresearchukorg/health‐professional/cancer‐statistics/sur...
1. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350–5. 10.1126/science.aar4060 - DOI - PMC - PubMed
1. Larson RC, Maus MV. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat Rev Cancer. 2021;21:145–61. 10.1038/s41568-020-00323-z - DOI - PMC - PubMed
1. Mullard A. 2021 FDA approvals. Nat Rev Drug Discov. 2022;21:83–8. 10.1038/d41573-022-00001-9 - DOI - PubMed
1. Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno AL, Le Toumelin‐Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477–82. 10.1038/nature19830 - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] UK CR . Cancer survival statistics for all cancers combined. 2022. [cited 2022 September 01]. Available from: https://wwwcancerresearchukorg/health‐professional/cancer‐statistics/sur...

[2] UK CR . Cancer survival statistics for all cancers combined. 2022. [cited 2022 September 01]. Available from: https://wwwcancerresearchukorg/health‐professional/cancer‐statistics/sur...

[3] Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350–5. 10.1126/science.aar4060 - DOI - PMC - PubMed

[4] Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350–5. 10.1126/science.aar4060 - DOI - PMC - PubMed

[5] Larson RC, Maus MV. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat Rev Cancer. 2021;21:145–61. 10.1038/s41568-020-00323-z - DOI - PMC - PubMed

[6] Larson RC, Maus MV. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat Rev Cancer. 2021;21:145–61. 10.1038/s41568-020-00323-z - DOI - PMC - PubMed

[7] Mullard A. 2021 FDA approvals. Nat Rev Drug Discov. 2022;21:83–8. 10.1038/d41573-022-00001-9 - DOI - PubMed

[8] Mullard A. 2021 FDA approvals. Nat Rev Drug Discov. 2022;21:83–8. 10.1038/d41573-022-00001-9 - DOI - PubMed

[9] Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno AL, Le Toumelin‐Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477–82. 10.1038/nature19830 - DOI - PubMed

[10] Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno AL, Le Toumelin‐Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477–82. 10.1038/nature19830 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Emerging concepts in drug discovery for cancer therapy

Affiliations

Emerging concepts in drug discovery for cancer therapy

Authors

Affiliations

Conflict of interest statement

Similar articles

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources